全胸腔镜下肺叶切除术在早期非小细胞肺癌治疗中的疗效及安全性

Efficacy and safety of total thoracoscopic lobectomy in the treatment of early stage non-small cell lung cancer

目的:探讨早期非小细胞肺癌患者行全胸腔镜辅助下肺叶切除术的临床价值。方法:2017年5月-2019年4月收治早期非小细胞肺癌患者176例,随机分为两组,各88例。观察组采取全胸腔镜辅助下肺叶切除术治疗;对照组采取传统开胸肺叶切除术治疗。比较两组常规围术期指标水平及并发症发生率。结果:两组胸腔引流量、引流时间、淋巴结清扫数量比较,差异无统计学意义(P>0.05);观察组术中失血量、手术时间及术后住院天数均少于对照组,术后并发症发生率低于对照组,差异均有统计学意义(P<0.05)。结论:对于早期非小细胞肺癌患者采取全胸腔镜辅助下的肺叶切除术效果理想,且安全性高。

Objective:To evaluate the clinical value of total thoracoscopic assisted lobectomy in patients with early stage non-small cell lung cancer.Methods:From May 2017 to April 2019,176 patients with early stage non-small cell lung cancer were enrolled,they were randomly divided into two groups with 88 cases in each group.The observation group was treated with total thoracoscopic assisted lobectomy and the control group was treated with traditional open thoracic lobectomy.The routine perioperative indicators and complication rates were compared between the two groups.Results:The thoracic drainage,the drainage time and the number of lymph node dissection were compared,the differences were not statistically significant(P>0.05).The blood loss,the operation time and the number of hospital stays in the observation group were less than in the control group,the incidence of postoperative complications was lower than the control group,the differences were statistically significant(P<0.05).Conclusion:Total thoracoscopic assisted lobectomy for early stage non-small cell lung cancer patients is ideal and safe.